Jean-François V.
- Country
- France
- Department
- Medecine interne et maladies infectieuses
Research Overview
- A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBEXELIMAB IN PATIENTS WITH IGG4-RELATED DISEASE (INDIGO)
- HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial. CAESAR
- Phase 1b Evaluation of CTPS1 Inhibitor STP938 in High-Risk Essential Thrombocythaemia Resistant or Intolerant to Hydroxycarbamide Therapy
Data & Insights
Has run more than one trial at 119 of 251 partner sites.
Specializations
Autoimmune Conditions
The investigator specializes in treating various autoimmune disorders, with particular focus on Systemic Lupus Erythematosus and IgG4-Related Disease. Their research extends to innovative therapeutic approaches for these conditions using novel immunological treatments.
- Lupus Management Studies
- IgG4-Related Disease Treatment
- Immune System Disorders
Hematological Disorders
Expertise in treating blood-related conditions, particularly focusing on Immune Thrombocytopenia and Essential Thrombocythemia. The investigator works with advanced therapeutic protocols including immunoglobulin treatments and novel agents.
- Autoimmune Hemolytic Anemia
- Thrombocytopenia Management
- Essential Thrombocythemia Treatment
Inflammatory Conditions
Specialized focus on inflammatory diseases including Giant Cell Arteritis and Eosinophilic Conditions. The investigator explores treatments for Castleman's Disease and various forms of vasculitis.
- Sarcoidosis Treatment
- Retroperitoneal Fibrosis
- ANCA-Associated Vasculitis
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.